NCT00672997View on ClinicalTrials.gov

A Phase III Study of Travoprost/Timolol Combination in Patients With Open-Angle Glaucoma or Ocular Hypertension

PHASE3CompletedINTERVENTIONAL
Enrollment

301

Participants

Timeline

Start Date

May 31, 2008

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions
Open-Angle GlaucomaOcular Hypertension
Interventions
DRUG

Travoprost 0.004%/Timolol 0.5% BAC-free ophthalmic solution

DRUG

Travoprost 0.004%/Timolol 0.5% ophthalmic solution

Sponsors

Lead Sponsor

Alcon Research
All Listed Sponsors
lead

Alcon Research

INDUSTRY